Wolfgang H Jost Selected Research

Wolfgang H Jost Research Topics

Disease

31	Parkinson Disease (Parkinson's Disease) 12/2022 - 09/2004
12	Torticollis (Wryneck) 01/2021 - 01/2007
11	Sialorrhea 05/2022 - 02/2010
8	Pain (Aches) 08/2021 - 03/2004
7	Stroke (Strokes) 10/2021 - 02/2014
6	Deglutition Disorders (Dysphagia) 05/2022 - 01/2015
5	Dyskinesias (Dyskinesia) 08/2021 - 02/2017
4	Multiple Sclerosis 10/2021 - 02/2006
3	Hemifacial Spasm 01/2022 - 04/2017
3	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2021 - 01/2019
3	Cerebral Palsy (Spastic Diplegia) 10/2021 - 01/2015
3	Parkinsonian Disorders (Parkinsonism) 12/2020 - 01/2019
3	Dystonic Disorders (Writer's Cramp) 01/2020 - 01/2007
3	Tremor (Tremors) 01/2020 - 01/2005
3	Orthostatic Hypotension (Postural Hypotension) 01/2020 - 03/2015
3	Muscle Spasticity (Spastic) 10/2015 - 09/2010
3	Blepharospasm 01/2015 - 09/2006
2	Movement Disorders (Movement Disorder) 01/2020 - 10/2015
2	Dizziness (Lightheadedness) 01/2020 - 03/2015
2	Multiple System Atrophy 01/2017 - 03/2015
2	Benign essential blepharospasm 06/2011 - 01/2007
2	Hypokinesia (Bradykinesia) 05/2007 - 01/2005
2	Restless Legs Syndrome (Restless Legs) 01/2005 - 09/2004
2	Fissure in Ano (Anal Fissure) 02/2004 - 09/2002
1	Diarrhea 10/2022
1	Mood Disorders (Mood Disorder) 08/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 09/2020
1	Corticobasal Degeneration 04/2020
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 04/2020
1	Hypotension (Low Blood Pressure) 01/2020
1	Dystonia (Limb Dystonia) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 10/2018
1	Urinary Incontinence 01/2017
1	Vertigo (Positional Vertigo) 03/2015
1	Muscle Weakness 01/2015
1	Nervous System Diseases (Neurological Disorders) 01/2015
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2015
1	Neck Pain (Cervicalgia) 01/2015
1	Blepharoptosis (Ptosis, Eyelid) 01/2015
1	Contracture 02/2014
1	Constipation 02/2010
1	Headache Disorders (Headache Syndromes) 11/2007
1	Strabismus (Squint) 09/2006
1	Migraine Disorders (Migraine) 09/2006
1	Stress Urinary Incontinence 12/2005
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2004
1	Atherosclerosis 09/2004

Drug/Important Bio-Agent (IBA)

24	Botulinum Toxins (Botulinum Toxin)IBA 05/2022 - 09/2002
16	Type A Botulinum Toxins (Botox)FDA Link 05/2022 - 02/2004
12	incobotulinumtoxinA FDA Link 05/2022 - 01/2007
11	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 09/2004
5	Pharmaceutical PreparationsIBA 05/2022 - 09/2006
5	safinamideIBA 08/2021 - 02/2017
5	3-Iodobenzylguanidine (Iobenguane)IBA 12/2020 - 05/2005
4	Cholinergic Antagonists (Anticholinergics)IBA 05/2022 - 02/2010
4	ropinirole (Requip)FDA LinkGeneric 09/2008 - 09/2004
3	Dopamine Agonists (Dopamine Agonist)IBA 09/2008 - 09/2004
2	entacapone (Comtan)FDA Link 10/2022 - 01/2022
2	Monoamine Oxidase (MAO)IBA 01/2022 - 10/2018
2	hydroxide ionIBA 01/2017 - 03/2015
2	abobotulinumtoxinA FDA Link 11/2016 - 02/2014
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2007
2	ErgolinesIBA 01/2005 - 09/2004
1	Adenosine A2 Receptor AntagonistsIBA 12/2022
1	Tolcapone (Tasmar)FDA Link 10/2022
1	opicaponeIBA 10/2022
1	catechol (pyrocatechol)IBA 10/2022
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2022
1	CannabinoidsIBA 01/2022
1	Synaptosomal-Associated Protein 25IBA 10/2021
1	tyramine-deoxysorbitolIBA 10/2021
1	Dopamine (Intropin)FDA LinkGeneric 08/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2020
1	amsonic acid (DAS)IBA 09/2020
1	benzothiazoleIBA 04/2020
1	propylene diquat (PDQ(+))IBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2018
1	Apomorphine FDA Link 01/2018
1	SolutionsIBA 11/2016
1	rasagiline (Azilect)FDA Link 11/2013
1	Pramipexole (Mirapex)FDA LinkGeneric 12/2010
1	Delayed-Action PreparationsIBA 12/2010
1	Biomarkers (Surrogate Marker)IBA 12/2010
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2010
1	Domperidone (Domperidon)IBA 02/2010
1	UbiquinoneIBA 07/2007
1	coenzyme Q10 (CoQ10)IBA 07/2007
1	Analgesics (Analgesic Drugs)IBA 09/2006
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 08/2006
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 12/2005
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 05/2005
1	NeurotoxinsIBA 09/2004

Therapy/Procedure

24	Therapeutics 12/2022 - 09/2004
10	Injections 01/2022 - 02/2010
2	Drug Therapy (Chemotherapy) 12/2019 - 02/2017
1	Pain Management 01/2020
1	Radiotherapy 12/2019
1	Operative Surgical Procedures 12/2019
1	Occupational Therapy (Therapy, Occupational) 02/2014